Health
Remyelinating drug shows potential to improve vision in patients with MS – News-Medical.Net
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl)…
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl) — has the potential to improve vision in patients with multiple sclerosis, or MS.
The study, performed on mice induced with a model of MS and the first to investigate IndCl’s effect on the pathology and function of the complete afferent visual pathway, is published in Brain Pathology. The afferent visual pathway includes the eyes, optic…
-
Noosa News22 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News22 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News24 hours agoHelicopter scrambles to site of air crash on K’gari
-
General20 hours agoTruck driver charged with causing death by dangerous driving after highway crash